Moreover, GP73, as a novel tissue biomarker, also is founded to occur in the development process of prostate cancer [37] and is down-regulated in gastric cancer and associated with tumor differentiation [38]; implying that GD55 has different effect for other types of cancers. This evidence concerns the gene GOLM1 and prostate cancer.